Formats
PDF report
Free
1.1MB
Another format
If you need this publication in an alternative format, please contact us.
Long COVID in Australia – a review of the literature
Publication
Release Date:
Topic: COVID-19
Citation
AIHW
Australian Institute of Health and Welfare (2022) Long COVID in Australia – a review of the literature, AIHW, Australian Government, accessed 01 November 2024.
APA
Australian Institute of Health and Welfare. (2022). Long COVID in Australia – a review of the literature. Canberra: AIHW.
MLA
Australian Institute of Health and Welfare. Long COVID in Australia – a review of the literature. AIHW, 2022.
Vancouver
Australian Institute of Health and Welfare. Long COVID in Australia – a review of the literature. Canberra: AIHW; 2022.
Harvard
Australian Institute of Health and Welfare 2022, Long COVID in Australia – a review of the literature, AIHW, Canberra.
PDF | 1.1MB
Long COVID is a multi-system illness characterised by ongoing persistent symptoms that can last for weeks or months following COVID-19 infection. This review investigates the scale and impact of long COVID in the Australian context. The review found that most information is from research conducted in the USA and UK on long COVID related to COVID-19 infections in the first two years (2020–21) of the pandemic.
- ISBN: 978-1-922802-49-1
- Cat. no: PHE 318
- Pages: 80
Findings from this report:
-
Around 5–10% of COVID-19 cases in Australia reported symptoms persisting for more than 3 months
-
Key risk factors include severe COVID-19 illness, comorbidities, female sex and mid-adult age groups
-
Up to September 2022, most long COVID research has been conducted outside of Australia, often using pre-Omicron data
-
Two COVID-19 vaccination doses are associated with a 13% to 47% lower risk of symptoms persisting beyond 4 weeks